Upstate Active Clinical Trials

Study Title:

Alliance A031201-Phase III Trial of Enzalutamide (NSC# 766085) Versus Enzalutamide, Abiraterone and Prednisone for Castration Resistant Metastatic Prostate Cancer

What is the purpose of the study?

This randomized phase III trial studies enzalutamide to see how well it works compared to enzalutamide, abiraterone acetate, and prednisone in treating patients with castration-resistant metastatic prostate cancer.

Upstate Institutional Review Board (IRB) Number:


Study Phase:


Patient Age Group:


Principal Investigator:

Sam Benjamin, MD

ClinicalTrials.Gov ID:


For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Lynn M Agostini, AAS
Phone: 315-464-8237

Return to Previous Page || Search Again